PBRM1 upregulated genes include targets of retinoic acid receptor [53, 54] and FOXO4 [55, 56] binding, in addition to HIF1α binding, all of which have been implicated in antagonizing ccRCC progression. The gene discussed is FOXO4; the disease is nonpapillary renal cell carcinoma.